Turn Therapeutics

TTRX Rare disease Lead: Phase 2 8 Biotech Distilled articles ↓

Most recent annual filing: 2026-03-31

Catalyst timeline

GX-03 eczema Ph2 toplinemid-2026GX-03 eczema Ph2 topline, mid-2026, thesis-defining
GX-03 eczema Ph2 toplinemid-2026GX-03 eczema Ph2 topline, mid-2026, thesis-defining
PermaFusion onychomycosis Ph3 start1Q 2027PermaFusion onychomycosis Ph3 start, 1Q 2027, routine
GX-03 onychomycosis Ph3 start2Q 2027GX-03 onychomycosis Ph3 start, 2Q 2027, routine

Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.

Pipeline (4 active programs)

GX-03

Small Molecule Target: IL-31, IL-36α/γ, IL-4, IL-36, IL-36α, IL-36γ

Onychomycosis Preclinical topical
Atopic Dermatitis Phase 2 topical NCT07355075
Hidradenitis Suppurativa Preclinical topical

intranasal influenza vaccine

Influenza nasal

Technology platforms

PermaFusion · Medline

PermaFusion is an oil-based suspension delivery platform enabling uniform delivery of water-soluble actives without emulsifiers; applications include thermostable intranasal live vaccine stabilization and dermatologic/antifungal product formulations. Focus areas include vaccines and dermatology.

PermaFusion

Multi-patented, API-agnostic topical drug delivery platform enabling stable, emulsifier-free dispersion of active ingredients in oil-based carriers; delivers APIs through skin, nails, and mucous membranes via suspended nanodroplets in petrolatum matrix; compatible with liquid or liquid-soluble APIs including live payloads; focus on dermatological and inflammatory diseases

Biotech Distilled coverage (8)

2026-08-19 UPDATE: Turn Therapeutics (TTRX) - GEM Cashed In Its Chips 🔒 Paid
2026-08-13 UPDATE: Turn Therapeutics (TTRX) - The GEM Facility Went Untouched 🔒 Paid
2026-07-07 UPDATE: Turn Therapeutics (TTRX) - The Vehicle-Response Problem Just Got a Prospective Fix 🔒 Paid
2026-06-02 UPDATE: Turn Therapeutics (TTRX) - The Interim Drops, and the Vehicle Arm Did Not Get the Memo 🔒 Paid
2026-05-18 UPDATE: Turn Therapeutics (TTRX) - A Former FDA Commissioner Walks Into a Pre-Readout Small-Cap 🔒 Paid
2026-05-12 UPDATE: Turn Therapeutics (TTRX) - The Interim Clock Just Moved Up 🔒 Paid
2026-03-28 UPDATE: Turn Therapeutics (TTRX) - TTRX Buys Time with a $25M Lifeline... 🔒 Paid
2026-03-19 Turn Therapeutics (TTRX) - Scientific Deep Dive for GX-03 and Pipeline Products 🔒 Paid

Articles open on Substack. Some deep dives are subscriber-only.